Impact of Asymmetric Stent Expansion on Neointimal Hyperplasia Following Sirolimus-Eluting Stent Implantation
- 15 November 2005
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 96 (10) , 1404-1407
- https://doi.org/10.1016/j.amjcard.2005.07.044
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Non–Polymer-Based Paclitaxel-Coated Coronary Stents for the Treatment of Patients With De Novo Coronary LesionsCirculation, 2004
- Inhibition of Restenosis With a Paclitaxel-Eluting, Polymer-Free Coronary StentCirculation, 2004
- A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- A Paclitaxel-Eluting Stent for the Prevention of Coronary RestenosisNew England Journal of Medicine, 2003
- Delivered Dose and Vascular Response After β-Radiation for In-Stent RestenosisCirculation, 2002
- 7-Hexanoyltaxol–Eluting Stent for Prevention of Neointimal GrowthCirculation, 2002
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationNew England Journal of Medicine, 2002
- Physiological Transport Forces Govern Drug Distribution for Stent-Based DeliveryCirculation, 2001
- Localized arterial wall drug delivery from a polymer-coated removable metallic stent. Kinetics, distribution, and bioactivity of forskolin.Circulation, 1994